PMID: 8604441Mar 1, 1996Paper

Cost and efficacy analysis in the ESVEM trial: implications for diagnosis and therapy for ventricular tachyarrhythmias

Progress in Cardiovascular Diseases
M A Hlatky

Abstract

Physicians must now consider the likely cost of management decisions as well as the expected effects on patient outcome. Cost-ascertainment studies identify and contrast the cost of therapies, and cost-effectiveness analysis compares the additional cost of a therapy with its additional effect on survival and quality of life. This article reviews the principles of cost-ascertainment and cost-effectiveness analysis and then presents the cost of initial and follow-up care in Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial. Finally, the cost-effectiveness of therapy guided by electrophysiologic study or Holter monitoring and of sotalol versus other drugs is reviewed, and implications for future studies are discussed.

References

Nov 1, 1984·The New England Journal of Medicine·G S ReederM K McAfee
Jan 1, 1982·Annals of Internal Medicine·S A Finkler
Mar 1, 1995·The American Journal of Cardiology·A P HallstromUNKNOWN AVID Investigators
Nov 1, 1994·Progress in Cardiovascular Diseases·J KupersmithJ Gardiner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.